Inscripta
Founded 2015 · CIK 0001667561 · Biotech · Acquired
Onyx digital genome editing platform enabling high-throughput CRISPR functional screens
inscripta.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $450M
- 14 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 17
- 0 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $3,000,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $6,035,341 | |
| Private capital raised | Form D · SEC | $22,999,995 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $1,005,358 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $55,499,974 | |
| Private capital raised | Form D · SEC | $1,146,592 | |
| Private capital raised | Form D · SEC | $25,649,982 | |
| Private capital raised | Form D · SEC | $92,149,960 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $8,060,048 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $49,999,996 | |
| Private capital raised | Form D · SEC | $149,999,970 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $4,399,977 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $27,791,098 | |
| Private capital raised | Form D · SEC | $1,855,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1507 | KINASENSE, LLC | — | — |
| 1508 | BRITEBIO, INC. | — | — |
| 1509 | MARROWSOURCE THERAPEUTICS INTERNATIONAL | — | — |
| 1510 | Inscripta | — | $450M |
| 1511 | Mirador Therapeutics | — | $413M |
| 1512 | BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC | — | — |
| 1513 | SYNCANICA BIO | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Dianna DeVoreExecutive Officer
- Justin FerberExecutive Officer
- Jason GammackExecutive Officer
- Andrew GarstPromoter
- Ryan GillDirector · Executive Officer · Promoter
- Michael GraigeExecutive Officer
- Kristala Jones PratherDirector
- Sri KosarajuDirector · Executive Officer
- Tanya LipscombDirector · Executive Officer · Promoter
- Ron McGrathExecutive Officer
- Eric MoessingerDirector
- Kevin NessDirector · Executive Officer
- Bryan RobertsDirector
- John StuelpnagelDirector
- Roger WyseDirector
Patents
- Phenotypic And Biological Assessment Of Microbesapplication
- Curing For Iterative Nucleic Acid-guided Nuclease Editingapplication
- Nucleic Acid-guided Nickase Fusion Proteinsapplication
- Strategies For Direct Recruitment Of Repair Templates To Crispr Nucleasesapplication
- Targeted Genomic Barcoding For Tracking Of Editing Eventsapplication
- Trackable Nucleic Acid-guided Editingapplication
- Processes For Measuring Strain Fitness And/or Genotype Selection In Bioreactorsapplication
- Genome-wide Rationally-designed Mutations Leading To Enhanced Cellobiohydrolase I Production In S. Cerevisiaeapplication
- Modules And Instruments For Automated Nucleic Acid-guided Nuclease Editing In Mammalian Cells Using Microcarriersapplication
- Nucleic Acid-guided Nickasesapplication
- Methods And Compositions Of Co-expression Of T7RNA Polymerase And Inhibitory Rna Aptamersapplication
- Microbial Production Of Fatty Alcoholsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.